申报总市值
US$4.4亿
申报季度: 2026-03-31 · 持股只数: 83
DAFNA Capital Management LLC在最新一期 13F 报告中披露了 83 项持股，申报期为 2026-03-31，总持股市值约为 US$4.4亿，季度换手率为 29.7%。
加仓 DAWNGBX
-2.1% US$1166.6万
减仓 CYTK
-41.4% -US$923.8万
加仓 NKTR
+120.2% US$871.4万
加仓 CMPS
+198.2% US$778.0万
减仓 AXGN
-47.6% -US$732.5万
加仓 RVMD
-3.9% US$832.1万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | 股票-医疗保健 | 12.85% | +1.67% | -3.94% | |
| 2 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 9.25% | — | -5.35% | |
| 3 | STXS | Stereotaxis INC | 股票-其他 | 5.73% | -1.58% | — | |
| 4 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 4.77% | +2.61% | -2.07% | |
| 5 | ATRC | Atricure INC | 股票-其他 | 3.88% | -1.61% | — | |
| 6 | IDYA | Ideaya Biosciences INC | 股票-其他 | 3.61% | -0.46% | -5.92% | |
| 7 | XENE | Xenon Pharmaceuticals INC | 股票-其他 | 3.32% | +0.32% | -12.91% | |
| 8 | CYTK | Cytokinetics INC | 股票-医疗保健 | 3.26% | -2.22% | -41.38% | |
| 9 | CMPS | Compass Pathways PLC | 股票-其他 | 3.04% | +1.74% | +198.24% | |
| 10 | NKTR | Nektar Therapeutics | 股票-其他 | 2.70% | +1.96% | +120.24% | |
| 11 | IBB | Ishares Biotechnology ETF | ETF-科技型 | 2.39% | -0.28% | -8.81% | |
| 12 | RCUS | Arcus Biosciences INC | 股票-其他 | 2.18% | -0.21% | +2.90% | |
| 13 | NBIX | Neurocrine Biosciences INC | 股票-医疗保健 | 2.12% | -0.21% | — | |
| 14 | LRMR | Larimar Therapeutics INC | 股票-其他 | 2.08% | +1.25% | +116.06% | |
| 15 | BCAX | Bicara Therapeutics INC | 股票-其他 | 1.91% | +0.89% | +61.22% | |
| 16 | AXGN | Axogen INC | 股票-其他 | 1.88% | -1.74% | -47.58% | |
| 17 | BHVN | Biohaven Ltd. | 股票-其他 | 1.63% | -0.87% | -11.46% | |
| 18 | TNDM | Tandem Diabetes Care INC | 股票-其他 | 1.55% | -0.26% | — | |
| 19 | DNLI | Denali Therapeutics INC | 股票-其他 | 1.39% | +0.17% | — | |
| 20 | ASND 2.25 04-01-28 | Ascendis Pharma A/s | 股票-其他 | 1.35% | — | — | |
| 21 | IPSC | Century Therapeutics INC | 股票-其他 | 1.25% | +0.60% | -12.86% | |
| 22 | DXCM | Dexcom INC | 股票-医疗保健 | 1.23% | — | -2.27% | |
| 23 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 1.22% | — | -25.06% | |
| 24 | ASND | Ascendis Pharma A/S | 股票-其他 | 1.21% | -0.19% | -17.75% | |
| 25 | MBX | Mbx Biosciences INC | 股票-其他 | 1.19% | — | +6.17% | |
| 26 | INGN | Inogen INC | 股票-其他 | 1.19% | — | +2.19% | |
| 27 | SNDX | Syndax Pharmaceuticals INC | 股票-其他 | 1.16% | -0.20% | -21.77% | |
| 28 | ALKS | Alkermes plc | 股票-医疗保健 | 1.12% | +0.27% | +7.09% | |
| 29 | STOK | Stoke Therapeutics INC | 股票-其他 | 0.97% | +0.17% | +20.21% | |
| 30 | BCRX | Biocryst Pharmaceuticals INC | 股票-其他 | 0.93% | +0.17% | +2.87% | |
| 31 | LKFT | Lakefront Biotherapeutic-adr | 股票-其他 | 0.89% | — | — | |
| 32 | IMVT | Immunovant INC | 股票-其他 | 0.85% | — | — | |
| 33 | EWTX | Edgewise Therapeutics INC | 股票-其他 | 0.80% | — | -29.74% | |
| 34 | MPLT | Maplight Therapeutics INC | 股票-其他 | 0.79% | +0.20% | +18.95% | |
| 35 | ALLO | Allogene Therapeutics INC | 股票-其他 | 0.76% | +0.32% | -0.72% | |
| 36 | PRCT | Procept Biorobotics CORP | 股票-其他 | 0.68% | -0.20% | — | |
| 37 | ALGN | Align Technology INC | 股票-医疗保健 | 0.58% | — | -6.25% | |
| 38 | ✓ | Proqr Thrapeutics N V | 股票-其他 | 0.58% | -0.16% | — | |
| 39 | HELP | Cybin INC | 股票-其他 | 0.54% | -0.32% | +9.53% | |
| 40 | RAPP | Rapport Therapeutics INC | 股票-其他 | 0.53% | — | — | |
| 41 | PODD | Insulet CORP | 股票-医疗保健 | 0.52% | — | +58.22% | |
| 42 | GPCR | Structure Therapeutics INC | 股票-其他 | 0.51% | — | +25.68% | |
| 43 | ✓ | Immatics NV | 股票-其他 | 0.51% | — | -13.51% | |
| 44 | CLDX | Celldex Therapeutics INC | 股票-其他 | 0.49% | — | — | |
| 45 | LXEO | Lexeo Therapeutics INC | 股票-其他 | 0.49% | -0.30% | +10.62% | |
| 46 | ALEC | Alector INC | 股票-其他 | 0.44% | +0.11% | — | |
| 47 | VKTX | Viking Therapeutics INC | 股票-医疗保健 | 0.44% | — | — | |
| 48 | KURA | Kura Oncology INC | 股票-其他 | 0.44% | — | — | |
| 49 | PROF | Profound Medical CORP | 股票-其他 | 0.39% | -0.13% | -7.95% | |
| 50 | FULC | Fulcrum Therapeutics INC | 股票-其他 | 0.36% | +0.36% | NEW |
Q3 2026表现
+16.4%
近4个季度表现
+86.3%
基于可获取价格的持仓（占申报价值的80%）计算
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 83 | US$4.4亿 | 30 | |
| 2025-12-31 | 77 | US$4.3亿 | 36 | |
| 2025-09-30 | 75 | US$4.0亿 | 41 | |
| 2025-06-30 | 76 | US$3.6亿 | 0 | |
| 2025-03-31 | 83 | US$3.5亿 | 100 | |
| 2024-12-31 | 82 | US$3.9亿 | 0 | |
| 2024-09-30 | 84 | US$4.2亿 | 0 | |
| 2024-06-30 | 83 | US$4.2亿 | 0 | |
| 2024-03-31 | 72 | US$4.4亿 | 0 | |
| 2023-12-31 | 76 | US$4.2亿 | 0 | |
| 2023-09-30 | 75 | US$3.2亿 | 0 | |
| 2023-06-30 | 73 | US$3.7亿 | 0 | |
| 2023-03-31 | 72 | US$3.3亿 | 0 | |
| 2022-12-31 | 79 | US$3.6亿 | 0 | |
| 2022-09-30 | 87 | US$3.7亿 | 0 | |
| 2022-06-30 | 90 | US$3.7亿 | 0 | |
| 2022-03-31 | 94 | US$3.8亿 | 0 | |
| 2021-12-31 | 87 | US$4.0亿 | 0 | |
| 2021-09-30 | 80 | US$3.8亿 | 0 | |
| 2021-06-30 | 84 | US$4.8亿 | 33 | |
| 2021-03-31 | 89 | US$4.2亿 | 43 | |
| 2020-12-31 | 74 | US$3.4亿 | 48 | |
| 2020-09-30 | 80 | US$3.1亿 | 44 | |
| 2020-06-30 | 87 | US$3.5亿 | 51 | |
| 2020-03-31 | 80 | US$2.4亿 | 48 | |
| 2019-12-31 | 81 | US$2.9亿 | 44 | |
| 2019-09-30 | 89 | US$2.7亿 | 32 | |
| 2019-06-30 | 87 | US$2.7亿 | 36 | |
| 2019-03-31 | 79 | US$2.3亿 | 58 | |
| 2018-12-31 | 83 | US$2.0亿 | 34 | |
| 2018-09-30 | 75 | US$2.4亿 | 24 | |
| 2018-06-30 | 75 | US$2.1亿 | 32 | |
| 2018-03-31 | 75 | US$2.1亿 | 44 | |
| 2017-12-31 | 72 | US$1.9亿 | 36 | |
| 2017-09-30 | 73 | US$1.6亿 | 39 | |
| 2017-06-30 | 75 | US$1.4亿 | 39 | |
| 2017-03-31 | 72 | US$1.2亿 | 47 | |
| 2016-12-31 | 66 | US$1.1亿 | 57 | |
| 2016-09-30 | 75 | US$1.4亿 | 58 | |
| 2016-06-30 | 95 | US$1.3亿 | 52 | |
| 2016-03-31 | 94 | US$1.2亿 | 58 | |
| 2015-12-31 | 78 | US$1.1亿 | 46 | |
| 2015-09-30 | 88 | US$1.0亿 | 42 | |
| 2015-06-30 | 76 | US$1.2亿 | 71 | |
| 2015-03-31 | 71 | US$1.3亿 | 48 | |
| 2014-12-31 | 62 | US$1.3亿 | 46 | |
| 2014-09-30 | 59 | US$9914.8万 | 48 | |
| 2014-06-30 | 49 | US$1.1亿 | 32 | |
| 2014-03-31 | 46 | US$1.2亿 | 40 | |
| 2013-12-31 | 47 | US$9715.6万 | 45 | |
| 2013-09-30 | 52 | US$9153.8万 | 53 | |
| 2013-06-30 | 44 | US$6832.6万 | 0 |
DAFNA Capital Management LLC 在 2026-03-31 最显著的持仓异动： 清仓: Astria Therapeutics INC (CATBUSD); 新建仓: Fulcrum Therapeutics INC (FULC); 新建仓: Orthopediatrics CORP (KIDS); 新建仓: Cytomx Therapeutics INC (CTMX); 新建仓: Maze Therapeutics INC (MAZE).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | DAWNGBX | Day One Biopharmaceuticals I | +2.6% | -2.07% | 减仓 |
| 2 | NKTR | Nektar Therapeutics | +2% | +120.24% | 加仓 |
| 3 | CMPS | Compass Pathways PLC | +1.7% | +198.24% | 加仓 |
| 4 | RVMD | Revolution Medicines INC | +1.7% | -3.94% | 减仓 |
| 5 | LRMR | Larimar Therapeutics INC | +1.3% | +116.06% | 加仓 |
| 6 | BCAX | Bicara Therapeutics INC | +0.9% | +61.22% | 加仓 |
| 7 | IPSC | Century Therapeutics INC | +0.6% | -12.86% | 减仓 |
| 8 | XENE | Xenon Pharmaceuticals INC | +0.3% | -12.91% | 减仓 |
| 9 | ALLO | Allogene Therapeutics INC | +0.3% | -0.72% | 减仓 |
| 10 | ALKS | Alkermes plc | +0.3% | +7.09% | 加仓 |
| 11 | MPLT | Maplight Therapeutics INC | +0.2% | +18.95% | 加仓 |
| 12 | RARE | Ultragenyx Pharmaceutical In | +0.2% | +281.88% | 加仓 |
| 13 | DNLI | Denali Therapeutics INC | +0.2% | — | 不变 |
| 14 | BCRX | Biocryst Pharmaceuticals INC | +0.2% | +2.87% | 加仓 |
| 15 | STOK | Stoke Therapeutics INC | +0.2% | +20.21% | 加仓 |
| 16 | NGNE | Neurogene INC | +0.1% | +102.46% | 加仓 |
| 17 | ALEC | Alector INC | +0.1% | — | 不变 |
| 18 | PROF | Profound Medical CORP | -0.1% | -7.95% | 减仓 |
| 19 | ✓ | Mediwound LTD | -0.1% | -16.91% | 减仓 |
| 20 | VRCA | Verrica Pharmaceuticals INC | -0.2% | -11.38% | 减仓 |
| 21 | ✓ | Proqr Thrapeutics N V | -0.2% | — | 不变 |
| 22 | ANNX | Annexon INC | -0.2% | -56.82% | 减仓 |
| 23 | ASND | Ascendis Pharma A/S | -0.2% | -17.75% | 减仓 |
| 24 | TELA | Tela Bio INC | -0.2% | — | 不变 |
| 25 | PRCT | Procept Biorobotics CORP | -0.2% | — | 不变 |
| 26 | SNDX | Syndax Pharmaceuticals INC | -0.2% | -21.77% | 减仓 |
| 27 | AQST | Aquestive Therapeutics INC | -0.2% | -2.00% | 减仓 |
| 28 | NBIX | Neurocrine Biosciences INC | -0.2% | — | 不变 |
| 29 | RCUS | Arcus Biosciences INC | -0.2% | +2.90% | 加仓 |
| 30 | SPRY | Ars Pharmaceuticals INC | -0.3% | -26.72% | 减仓 |
| 31 | TNDM | Tandem Diabetes Care INC | -0.3% | — | 不变 |
| 32 | IBB | Ishares Biotechnology ETF | -0.3% | -8.81% | 减仓 |
| 33 | LXEO | Lexeo Therapeutics INC | -0.3% | +10.62% | 加仓 |
| 34 | HELP | Cybin INC | -0.3% | +9.53% | 加仓 |
| 35 | IDYA | Ideaya Biosciences INC | -0.5% | -5.92% | 减仓 |
| 36 | BHVN | Biohaven Ltd. | -0.9% | -11.46% | 减仓 |
| 37 | STXS | Stereotaxis INC | -1.6% | — | 不变 |
| 38 | ATRC | Atricure INC | -1.6% | — | 不变 |
| 39 | AXGN | Axogen INC | -1.7% | -47.58% | 减仓 |
| 40 | CYTK | Cytokinetics INC | -2.2% | -41.38% | 减仓 |
| 41 | CATBUSD | Astria Therapeutics INC | — | EXIT | 清仓 |
| 42 | FULC | Fulcrum Therapeutics INC | — | NEW | 新建仓 |
| 43 | KIDS | Orthopediatrics CORP | — | NEW | 新建仓 |
| 44 | CTMX | Cytomx Therapeutics INC | — | NEW | 新建仓 |
| 45 | MAZE | Maze Therapeutics INC | — | NEW | 新建仓 |
| 46 | SCYXEUR | Scynexis INC | — | NEW | 新建仓 |
| 47 | ERAS | Erasca INC | — | EXIT | 清仓 |
| 48 | ZBIO | Zenas Biopharma INC | — | NEW | 新建仓 |
| 49 | NAMS | NewAmsterdam Pharma Company N.V. | — | NEW | 新建仓 |
| 50 | PLRX | Pliant Therapeutics INC | — | NEW | 新建仓 |